glp-1 alzheimer's study Could diabetes and weight loss drugs treat disease? GLP-1s tied to a 'particularly

A 2022 systematic review and meta-analysis published in JAMA Internal Medicine found that GLP-1 receptor agonist use was associated with increased risk of biliary disease, with an overall relative risk of approximately 1.37

Gastric Bypass NSAIDs and steroids may be restricted because of ulcer risk

and Mills, K.A., 1995

Why receptor subtype work matters for interpretation A common question is which receptor subtype is doing the work. A 2025 mechanistic study investigated AMY receptor subtype dependence and reported that cagrilintides body weight lowering effects depended on AMY1R and AMY3R in their models, which provides a more concrete receptor anchored explanation than general appetite language

Navigating the B(12) road: assimilation, delivery, and disorders of cobalamin